BIT
MRNS

BlackRock Institutional Trust’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BlackRock Institutional Trust’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$118K Buy
29,128
+23,389
+408% +$109K ﹤0.01% 3643
2016
Q3 		$42K Hold
5,739
– – ﹤0.01% 3763
2016
Q2 		$29K Sell
5,739
-4,251
-43% -$78.3K ﹤0.01% 3794
2016
Q1 		$215K Sell
9,990
-1,753
-15% -$37.1K ﹤0.01% 3622
2015
Q4 		$359K Buy
11,743
+10,513
+855% +$308K ﹤0.01% 3558
2015
Q3 		$41K Buy
+1,230
New +$69.4K ﹤0.01% 3830
2015
Q2 		– Sell
-397
Closed -$14K – 3977
2015
Q1 		$14K Buy
+397
New +$17.4K ﹤0.01% 3812

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return